Atlanta, GA, United States of America

Asiya Seema Chida

This inventor holds 1 USPTO granted patent. Top assignees: Georgia Tech Research Corporation, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.


Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Asiya Seema Chida: Innovator in SARS-CoV-2 Detection and Treatment

Introduction

Asiya Seema Chida is a notable inventor based in Atlanta, GA. He has made significant contributions to the field of medical science, particularly in the detection and treatment of viral infections. His work has been instrumental in addressing public health challenges, especially during the COVID-19 pandemic.

Latest Patents

Asiya Seema Chida holds a patent titled "Compositions and Methods for the Detection and Treatment of SARS-CoV-2 Virus Infection." This patent represents a crucial advancement in the fight against COVID-19, providing methods that could enhance detection and treatment options for those infected with the virus. He has 1 patent to his name.

Career Highlights

Throughout his career, Chida has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and Georgia Tech Research Corporation. His experience in these institutions has allowed him to contribute to significant research and development projects.

Collaborations

Chida has collaborated with various professionals in his field, including colleagues such as Mg Finn and Asheley Chapman. These collaborations have fostered innovation and have been essential in advancing his research efforts.

Conclusion

Asiya Seema Chida is a distinguished inventor whose work in the detection and treatment of SARS-CoV-2 has made a lasting impact on public health. His contributions continue to be relevant in the ongoing fight against viral infections.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…